{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:53:51Z","timestamp":1787504031935,"version":"build-2736575974"},"reference-count":67,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Poor recognition of subtle clinical abnormalities and equivocal ACTH concentrations make early diagnosis of PPID difficult. Progressive clinical findings and corresponding ACTH concentrations in horses transitioning to PPID over time have not been documented. Seven horses with ACTH concentrations equivocal for PPID (utilizing locally derived, seasonally adjusted diagnostic-cut off values (DCOV)) and no clinical signs of PPID were selected. Sequential measurement of basal and thyrotropin-releasing hormone (TRH)-stimulated ACTH concentrations and recording of clinical findings occurred from October 2017 to November 2021 in a prospective case series. In two horses, marked hypertrichosis developed. Although 1\/11 basal ACTH concentrations were below DCOV in 2018, subsequently all basal ACTH concentrations in these two horses without treatment were greater than DCOV. One horse was treated with pergolide which normalized basal ACTH concentrations. Four horses developed intermittent, mild hypertrichosis, and one horse never developed hypertrichosis. Basal ACTH concentrations in these five horses were greater than DCOV in 63\/133 (47.4%) of testing points. TRH-stimulated ACTH concentrations in these five horses were greater than DCOV in 77\/133 (57.9%) of testing points, sometimes markedly increased and greater than the assay upper limit of detection (LoD) of 1250pg\/mL. TRH-stimulated ACTH concentrations were most frequently positive in late summer and early autumn, with 24\/37 (64.9%) of TRH-stimulated ACTH concentrations greater than the DCOV in February and March. Horses transitioning to PPID can have subtle clinical signs and equivocal ACTH concentrations. However, TRH-stimulated ACTH concentrations can be markedly greater than DCOV, especially in late summer and early autumn (February and March) allowing for identification of subclinical and transitional cases.<\/jats:p>","DOI":"10.3390\/vetsci9100572","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:31:01Z","timestamp":1666053061000},"page":"572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID)"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-4014","authenticated-orcid":false,"given":"Naomi C.","family":"Kirkwood","sequence":"first","affiliation":[{"name":"School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-6268","authenticated-orcid":false,"given":"Kristopher J.","family":"Hughes","sequence":"additional","affiliation":[{"name":"School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-3954","authenticated-orcid":false,"given":"Allison J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"School of Veterinary Science, Gatton Campus, The University of Queensland, Gatton, QLD 4343, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/eve.12160","article-title":"Pituitary pars intermedia dysfunction: Diagnosis and treatment","volume":"26","author":"Durham","year":"2014","journal-title":"Equine Vet. Educ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jvim.16017","article-title":"Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses","volume":"35","author":"Horn","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tvjl.2018.03.002","article-title":"Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors","volume":"235","author":"Ireland","year":"2018","journal-title":"Vet. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.2042-3306.2012.00578.x","article-title":"Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses","volume":"45","author":"McGowan","year":"2013","journal-title":"Equine Vet. J."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kirkwood, N.C., Hughes, K.J., and Stewart, A.J. (2022). Review Article: Pituitary Pars Intermedia Dysfunction (PPID) in Horses. Vet. Sci., 9.","DOI":"10.3390\/vetsci9100556"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1038\/s41598-021-95396-7","article-title":"Equine pituitary pars intermedia dysfunction: A spontaneous model of synucleinopathy","volume":"11","author":"Fortin","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2460\/ajvr.2005.66.2065","article-title":"Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses","volume":"66","author":"McFarlane","year":"2005","journal-title":"Am. J. Vet. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.rvsc.2022.08.018","article-title":"Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction","volume":"152","author":"Huang","year":"2022","journal-title":"Res. Vet. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Carmalt, J.L., Mortazavi, S., McOnie, R.C., Allen, A.L., and Unniappan, S. (2018). Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction. PLoS One, 13.","DOI":"10.1371\/journal.pone.0190796"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/030098589902700606","article-title":"Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses","volume":"27","author":"Heinrichs","year":"1990","journal-title":"Vet. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1210\/endo-110-4-1430","article-title":"Equine Cushing\u2019s disease: Plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests","volume":"110","author":"Orth","year":"1982","journal-title":"Endocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/endo-110-3-941","article-title":"Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing\u2019s horses","volume":"110","author":"Wilson","year":"1982","journal-title":"Endocrinology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1294\/jes.12.119","article-title":"Spontaneous Pituitary Adenomas of the Pars Intermedia in 5 Aged Horses: Histopathological, Immunohistochemical and Ultrastructural Studies","volume":"12","author":"Yoshikawa","year":"2001","journal-title":"J. Equine Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/evj.13041","article-title":"Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction","volume":"51","author":"Horn","year":"2019","journal-title":"Equine Vet. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1939-1676.2012.00932.x","article-title":"Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993\u20132004","volume":"26","author":"Rohrbach","year":"2012","journal-title":"J. Vet. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1354\/vp.45-1-26","article-title":"Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction","volume":"45","author":"Miller","year":"2008","journal-title":"Vet. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2460\/javma.231.3.417","article-title":"Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia","volume":"231","author":"Beech","year":"2007","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_18","first-page":"261","article-title":"Equine pituitary pars intermedia dysfunction: An international survey of veterinarians\u2019 approach to diagnosis, management, and estimated prevalence","volume":"81","author":"Carmalt","year":"2017","journal-title":"Can. J. Vet. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1939-1676.2005.tb02674.x","article-title":"Diagnosing equine pars intermedia dysfunction: Are we there yet?","volume":"19","author":"Toribio","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"ref_20","first-page":"987","article-title":"Evaluation of the combined dexamethasone suppression\/ thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses","volume":"20","author":"Frank","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0739-7240(94)00006-M","article-title":"Laboratory diagnosis of equine pituitary pars intermedia adenoma","volume":"12","author":"Wensing","year":"1995","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_22","unstructured":"Hart, K., Durham, A., Frank, N., McGowan, C., Schott, H., and Stewart, A.J. (2021, November 11). EEG Recommendations on Diagnosis and Management of Pituitary Pars Intermedia Dysfunction (PPID). Available online: https:\/\/sites.tufts.edu\/equineendogroup\/files\/2021\/12\/2021-PPID-Recommendations-V11-wo-insert.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2460\/javma.241.2.241","article-title":"Seasonal variation in results of diagnostic tests for pituitary pars intermedia dysfunction in older, clinically normal geldings","volume":"241","author":"Schreiber","year":"2012","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.2042-3306.2012.00575.x","article-title":"Evaluation of basal plasma \u03b1-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses","volume":"45","author":"Pinchbeck","year":"2013","journal-title":"Equine Vet. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/evj.13292","article-title":"Clinically and temporally specific diagnostic thresholds for plasma ACTH in the horse","volume":"53","author":"Durham","year":"2021","journal-title":"Equine Vet. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/jvim.15617","article-title":"Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses","volume":"33","author":"Horn","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_27","unstructured":"Robinson, N.E., and Sprayberry, K.A. (2015). Pituitary pars intermedia dysfunction. Robinson\u2019s Current Therapy in Equine Medicine, Elsevier Inc.. [7th ed.]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1939-1676.2011.0712.x","article-title":"Seasonal changes in plasma adrenocorticotropic hormone and \u03b1-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses","volume":"25","author":"Funk","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.2042-3306.2011.00444.x","article-title":"Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction","volume":"44","author":"Copas","year":"2012","journal-title":"Equine Vet. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/avj.12716","article-title":"Equine pituitary pars intermedia dysfunction: Current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group","volume":"96","author":"Secombe","year":"2018","journal-title":"Aust. Vet. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1677\/joe.0.1570425","article-title":"The effect of social stress on adrenal axis activity in horses: The importance of monitoring corticosteroid-binding globulin capacity","volume":"157","author":"Alexander","year":"1998","journal-title":"J. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1677\/joe.0.1160325","article-title":"Effect of isolation stress on concentrations of arginine vasopressin, \u03b1-melanocyte-stimulating hormone and ACTH in the pituitary venous effluent of the normal horse","volume":"116","author":"Alexander","year":"1988","journal-title":"J. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/endo-128-1-65","article-title":"The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse","volume":"128","author":"Alexander","year":"1991","journal-title":"Endocrinology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.domaniend.2017.10.005","article-title":"Effect of dietary carbohydrates and time of year on ACTH and cortisol concentrations in adult and aged horses","volume":"63","author":"Jacob","year":"2018","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jvim.15620","article-title":"Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome","volume":"33","author":"Stewart","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/vcp.12006","article-title":"ASVCP reference interval guidelines: Determination of de novo reference intervals in veterinary species and other related topics","volume":"41","author":"Friedrichs","year":"2012","journal-title":"Vet. Clin. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.domaniend.2014.02.004","article-title":"Influence of feeding status, time of the day, and season on baseline adrenocorticotropic hormone and the response to thyrotropin releasing hormone-stimulation test in healthy horses","volume":"48","author":"Lopez","year":"2014","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/jvim.15771","article-title":"The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses","volume":"34","author":"Hu","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1111\/jvim.16281","article-title":"Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses","volume":"35","author":"Kam","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hinrichsen, S.L., Yuen, K.Y., Dryburgh, E.L., Bertin, F.R., and Stewart, A.J. (2022). Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses. Animals, 12.","DOI":"10.3390\/ani12030324"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tvjl.2018.07.008","article-title":"Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia","volume":"238","author":"Byrne","year":"2018","journal-title":"Vet. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1939-1676.2010.0547.x","article-title":"Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction","volume":"24","author":"Frank","year":"2010","journal-title":"J. Vet. Intern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/vcp.12326","article-title":"Initial analytic quality assessment and method comparison of an immunoassay for adrenocorticotropic hormone measurement in equine samples","volume":"45","author":"Irvine","year":"2016","journal-title":"Vet. Clin. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cveq.2010.12.007","article-title":"Equine Pituitary Pars Intermedia Dysfunction","volume":"27","author":"McFarlane","year":"2011","journal-title":"Vet. Clin. North. Am. Equine Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.1996.tb02016.x","article-title":"Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism","volume":"10","author":"Paradis","year":"1996","journal-title":"J. Vet. Intern. Med."},{"key":"ref_46","first-page":"212-e247","article-title":"Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses","volume":"24","author":"Petersen","year":"2013","journal-title":"Vet. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2460\/javma.2003.223.93","article-title":"Demographic and clinical characteristics of geriatric horses: 467 cases (1989\u20131999)","volume":"223","author":"Brosnahan","year":"2003","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/vr.149.14.417","article-title":"Sentinel practice-based survey of the management and health of horses in northern Britain","volume":"149","author":"Mellor","year":"2001","journal-title":"Vet. Rec."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vetimm.2015.04.006","article-title":"Neutrophil function in healthy aged horses and horses with pituitary dysfunction","volume":"165","author":"McFarlane","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2460\/ajvr.77.11.1236","article-title":"Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction","volume":"77","author":"Hart","year":"2016","journal-title":"Am. J. Vet. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1751-0813.2012.00997.x","article-title":"Case series of equine pituitary pars intermedia dysfunction in a tropical climate","volume":"90","author":"Spelta","year":"2012","journal-title":"Aust. Vet. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0749-0739(02)00018-4","article-title":"Pituitary pars intermedia dysfunction: Equine Cushing\u2019s disease","volume":"18","author":"Schott","year":"2002","journal-title":"Vet. Clin. North. Am. Equine Pract."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/eve.12237","article-title":"Pathophysiology and clinical features of pituitary pars intermedia dysfunction","volume":"26","author":"McFarlane","year":"2014","journal-title":"Equine Vet. Educ."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"110207","DOI":"10.1016\/j.vetimm.2021.110207","article-title":"Investigation of innate immune function in adult and geriatric horses","volume":"235","author":"Miller","year":"2021","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"106531","DOI":"10.1016\/j.domaniend.2020.106531","article-title":"Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses","volume":"74","author":"Miller","year":"2021","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2460\/ajvr.74.7.1030","article-title":"Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses","volume":"74","author":"Miller","year":"2013","journal-title":"Am. J. Vet. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0300985815608674","article-title":"What\u2019s new in old horses? Postmortem diagnoses in mature and aged equids","volume":"53","author":"Miller","year":"2016","journal-title":"Vet. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1939-1676.2011.00810.x","article-title":"Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction","volume":"25","author":"Beech","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jvim.16362","article-title":"Effect of early or late blood sampling on thyrotropin releasing hormone stimulation test results in horses","volume":"36","author":"Thane","year":"2022","journal-title":"J. Vet. Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"McGowan, C. (2013). Hyperadrenocorticism (Pituitary Pars Intermedia Dysfunction) in Horses, John Wiley & Sons, Inc.. [1st ed.].","DOI":"10.1002\/9781118997093.ch11"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"105562","DOI":"10.1016\/j.tvjl.2020.105562","article-title":"Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review","volume":"266","author":"Tatum","year":"2020","journal-title":"Vet. J."},{"key":"ref_62","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing\u2019s disease)","volume":"16","author":"Donaldson","year":"2002","journal-title":"J. Vet. Intern. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing\u2019s disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Vet. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"106620","DOI":"10.1016\/j.domaniend.2021.106620","article-title":"Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy","volume":"76","author":"Banse","year":"2021","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2460\/javma.238.10.1305","article-title":"\u03b1-Melanocyte\u2014stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction","volume":"238","author":"Beech","year":"2011","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.domaniend.2005.07.005","article-title":"Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants","volume":"30","author":"McFarlane","year":"2006","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2460\/ajvr.2005.66.2055","article-title":"Agreement in histologic assessments of the pituitary pars intermedia in aged horses","volume":"66","author":"McFarlane","year":"2005","journal-title":"Am. J. Vet. Res."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/9\/10\/572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:39Z","timestamp":1760144139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/9\/10\/572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["vetsci9100572"],"URL":"https:\/\/doi.org\/10.3390\/vetsci9100572","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}